• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NHF

NIB HOLDINGS LIMITED - Charts / Financials

0.15% ! $6.83
Market Cap $3.326B  !
Financial Services Insurance - Life
Add to My Watchlist

nib Holdings Limited is an Australia-based provider of health and medical insurance. The... nib Holdings Limited is an Australia-based provider of health and medical insurance. The Company’s segments include Australian Residents Health Insurance, New Zealand Insurance, International (Inbound) Health Insurance, nib Travel and nib Thrive. The Australian Residents Health Insurance segment offers products within the Australian private health insurance industry, including the Australian Payer to Partner (P2P) product offering and commission from other insurance products. Its New Zealand Insurance segment offers products within the New Zealand private health and life insurance industry, and commission from other insurance products. Its International (Inbound) Health Insurance segment offers health insurance products for international students and workers. Its nib Travel segment is engaged in the distribution of travel insurance products. Through its nib Thrive segment, the Company’s offering as a Plan Manager under the National Disability Insurance Scheme (NDIS).More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 15/05/2025 (20 minute delay) ?
Day
Open $6.84   Day High $6.85   Day Low $6.78
Daily Volume 984128
Bids   Sellers
Number Price Volume   Number Price Volume
1 $6.81 3247   2 $6.85 300

Directors & Senior Management

Mr. Edward Close Chief Executive Officer, Managing Director, Director
Mr. Nick Freeman Group Chief Financial Officer
Mr. Martin Adlington Chief Executive - Nib Thrive
Mr. James Barr Chief Executive - International Visitors
Mr. Rob Hennin Chief Executive Officer - NIB New Zealand & Travel
Ms. Lauren Daniels Group Chief People Officer
Mr. Brendan Mills Group Chief Information Officer
Ms. Roslyn Toms Group Executive Legal and Chief Risk Officer, Company Secretary
Mr. David Robert Gordon Independent Non-Executive Chairman of the Board
Ms. Jacqueline Chow Independent Non-Executive Director
Mr. Peter Geoffrey Harmer Independent Non-Executive Director
Ms. Anne Joan Loveridge Independent Non-Executive Director
Mr. Donal Paul O'Dwyer Independent Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$6.83 		Change
0.010(0.15%) 		Mkt cap ! $3.326B
Open High Low Value Volume
$6.84 $6.85 $6.78 $6.718M 984.1K

Buyers (Bids)

No. Vol. Price($)
1 3247 $6.81
 

Sellers (Offers)

Price($) Vol. No.
$6.85 300 2
View Market Depth
Last trade - 16.10pm 15/05/2025 (20 minute delay) ?
Last
$6.83 		  Change
0.010 ( 0.34 %)
Open High Low Volume
$6.82 $6.85 $6.78 147472
Last updated 15.59pm 15/05/2025 ?

Top Stories

‘Spectacular results’: Odyssey Gold (ASX:ODY) prepares for Au production

An airborne survey electromagnetic survey has identified @32’ new promising exploration targets within Odyssey Gold @s (ASX:ODY) Tuckanarra project.Tuckanarra, near Meekatharra in WA, has been of interest to miners over many decades @ there are four existing open pits there, along...
Metgasco (ASX:MEL) kicks off Entitlement Offer to accelerate gas production and cashflow Metgasco (ASX:MEL) is conducting a partially underwritten shareholder entitlement offer to raise up to $750,000 at 0.2 cents per share. This is a 33% discount to the current 0.3 cents share price, 1 new share for every 3.89 existing shares (Record Date: 14 May 2025).Managing Director Ken Aitken j...
Record gold prices, overlooked acreage & a looming maiden JORC. How this stock could become a household name As the gold metal has cooled from the ~US$3,500/oz mark in recent weeks, the commodity's performance through CY2024, and year...
Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks...
Gold, niobium, helium and more: Which explorers found what on Thursday? It can be hard to keep an eye on all of the ASX explorers. Here's what caught eyes on Thursday when it comes to junior...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.